BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 19396233)

  • 1. Motoneurons buckling under stress.
    Markus A
    Nat Neurosci; 2009 May; 12(5):534. PubMed ID: 19396233
    [No Abstract]   [Full Text] [Related]  

  • 2. Determinants of rapid disease progression in ALS.
    Yamanaka K; Cleveland DW
    Neurology; 2005 Dec; 65(12):1859-60. PubMed ID: 16380607
    [No Abstract]   [Full Text] [Related]  

  • 3. Bcl2a1 serves as a switch in death of motor neurons in amyotrophic lateral sclerosis.
    Crosio C; Casciati A; Iaccarino C; Rotilio G; Carrì MT
    Cell Death Differ; 2006 Dec; 13(12):2150-3. PubMed ID: 16710367
    [No Abstract]   [Full Text] [Related]  

  • 4. Edaravone in ALS.
    Takahashi R
    Exp Neurol; 2009 Jun; 217(2):235-6. PubMed ID: 19285071
    [No Abstract]   [Full Text] [Related]  

  • 5. GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis.
    Carunchio I; Mollinari C; Pieri M; Merlo D; Zona C
    Eur J Neurosci; 2008 Oct; 28(7):1275-85. PubMed ID: 18973555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyotrophic lateral sclerosis: pathogenesis.
    Robberecht W; Van Den Bosch L; Vleminckx V
    Acta Neurol Belg; 2000 Sep; 100(3):181-7. PubMed ID: 11098292
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapid disease progression correlates with instability of mutant SOD1 in familial ALS.
    Sato T; Nakanishi T; Yamamoto Y; Andersen PM; Ogawa Y; Fukada K; Zhou Z; Aoike F; Sugai F; Nagano S; Hirata S; Ogawa M; Nakano R; Ohi T; Kato T; Nakagawa M; Hamasaki T; Shimizu A; Sakoda S
    Neurology; 2005 Dec; 65(12):1954-7. PubMed ID: 16291929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The proapoptotic BCL-2 family member BIM mediates motoneuron loss in a model of amyotrophic lateral sclerosis.
    Hetz C; Thielen P; Fisher J; Pasinelli P; Brown RH; Korsmeyer S; Glimcher L
    Cell Death Differ; 2007 Jul; 14(7):1386-9. PubMed ID: 17510659
    [No Abstract]   [Full Text] [Related]  

  • 9. Disease-dependent reciprocal phosphorylation of serine and tyrosine residues of c-Met/HGF receptor contributes disease retardation of a transgenic mouse model of ALS.
    Kadoyama K; Funakoshi H; Ohya-Shimada W; Nakamura T; Matsumoto K; Matsuyama S; Nakamura T
    Neurosci Res; 2009 Oct; 65(2):194-200. PubMed ID: 19595710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of labile zinc in neurons and astrocytes in the spinal cords of G93A SOD-1 transgenic mice.
    Kim J; Kim TY; Hwang JJ; Lee JY; Shin JH; Gwag BJ; Koh JY
    Neurobiol Dis; 2009 May; 34(2):221-9. PubMed ID: 19344646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New treatments in amyotrophic lateral sclerosis.
    Maragakis N; Rothstein JD
    Neuropsychopharmacology; 2011 Jan; 36(1):370-2. PubMed ID: 21116264
    [No Abstract]   [Full Text] [Related]  

  • 12. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA.
    Wang J; Xu G; Slunt HH; Gonzales V; Coonfield M; Fromholt D; Copeland NG; Jenkins NA; Borchelt DR
    Neurobiol Dis; 2005 Dec; 20(3):943-52. PubMed ID: 16046140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is erythropoietin a potential therapy for amyotrophic lateral sclerosis?
    Butsch PO; Cudkowicz ME
    Exp Neurol; 2007 Jul; 206(1):11-5. PubMed ID: 17498699
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Sharp PS; Dick JR; Greensmith L
    Neuroscience; 2005; 130(4):897-910. PubMed ID: 15652988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo.
    Chi L; Ke Y; Luo C; Gozal D; Liu R
    Neuroscience; 2007 Feb; 144(3):991-1003. PubMed ID: 17150307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice.
    Saxena S; Cabuy E; Caroni P
    Nat Neurosci; 2009 May; 12(5):627-36. PubMed ID: 19330001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS.
    Robertson J; Sanelli T; Xiao S; Yang W; Horne P; Hammond R; Pioro EP; Strong MJ
    Neurosci Lett; 2007 Jun; 420(2):128-32. PubMed ID: 17543992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular biology of amyotrophic lateral sclerosis: insights from genetics.
    Pasinelli P; Brown RH
    Nat Rev Neurosci; 2006 Sep; 7(9):710-23. PubMed ID: 16924260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Krishnan J; Vannuvel K; Andries M; Waelkens E; Robberecht W; Van Den Bosch L
    J Neurochem; 2008 Sep; 106(5):2170-83. PubMed ID: 18624915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No widespread induction of cell death genes occurs in pure motoneurons in an amyotrophic lateral sclerosis mouse model.
    Perrin FE; Boisset G; Docquier M; Schaad O; Descombes P; Kato AC
    Hum Mol Genet; 2005 Nov; 14(21):3309-20. PubMed ID: 16192287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.